MediPharm Labs (TSE:LABS) Shares Down 12.5% – Time to Sell?

MediPharm Labs Corp. (TSE:LABSGet Free Report)’s stock price dropped 12.5% during trading on Friday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 27,310 shares traded hands during trading, a decline of 93% from the average daily volume of 378,419 shares. The stock had previously closed at C$0.08.

MediPharm Labs Stock Performance

The company has a market capitalization of C$31.12 million, a price-to-earnings ratio of -2.58 and a beta of 0.88. The stock’s 50 day moving average price is C$0.07 and its 200 day moving average price is C$0.07. The company has a current ratio of 3.21, a quick ratio of 3.10 and a debt-to-equity ratio of 1.45.

About MediPharm Labs

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Recommended Stories

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.